DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
75	クッシング病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-002063-26-IT (EUCTR)	08/09/2013	23/07/2013	A trial with Metyrapone in Cushing's syndrome	A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with ACTH-independent Cushing’s syndrome due to adrenal adenoma. - METYX01	Cushing's syndrome;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Trade Name: Matyrapone Product Name: Metyrapone Product Code: Metyrapone	S.C.D.U. MEDICINA INTERNA 1 Ospedale San Luigi Orbassano	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15	Phase 2	Italy

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2013-002063-26-IT
(EUCTR)

08/09/2013

23/07/2013

A trial with Metyrapone in Cushing's syndrome

A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with ACTH-independent Cushing’s syndrome due to adrenal adenoma. - METYX01

Cushing's syndrome;Therapeutic area: Diseases [C] - Hormonal diseases [C19]

Trade Name: Matyrapone
Product Name: Metyrapone
Product Code: Metyrapone

S.C.D.U. MEDICINA INTERNA 1 Ospedale San Luigi Orbassano

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

Phase 2

Italy